Since red cells are the major target of the malarial parasite and as such are destined for premature destruction, should this not adequately explain the sometimes life-threatening fall in haemoglobin seen in this infection? Such an explanation is obviously inadequate, for the degree of anaemia is often far in excess of that accounted for by the removal of infected cells alone. These factors make the anaemia of malaria both an important clinical complication and a challenging biological problem in one of the most common infections of man.
G. Pasvol cells could favour mechanical lysis in organs such as the spleen [7] . The paper of Phillips et al. does not address these two aspects of haemolysis, but provides good evidence against another pathway of red cell destruction, namely disseminated intravascular coagulation. Although 46 of 116 patients had raised fibrin degradation products, in only 13 was this associated with hypofibrinogenaemia. On the contrary there was a significant increase in plasma fibrinogen in patients with cerebral malaria when compared to controls. Bleeding was uncommon.
In the face of extensive haemolysis and in the absence of haematinic deficiency, it is surprising that the marrow appearances in acute malaria are often of normal or decreased haemopoiesis. However, recent evidence with malaria in mice would indicate that the decrease in marrow activity even precedes any change in haematocrit [8] . In addition dyserythropoiesis, previously seen in longstanding malarial infections [9] has now been documented by Phillips et al. in these rather acute cases. This ineffective erythropoiesis can only further contribute to the anaemia. Dyserythropoiesis is found in a wide variety of conditions such as megaloblastic anaemias, haemoglobinopathies, severe iron deficiency, neoplastic disorders and now malaria must be added to this list. The challenge of dyserythropoiesis is twofold. Firstly the basis of the marrow abnormality and how the parasite brings it about needs to be established. Does the parasite for example, produce a specific product toxic to erythroid precursors? Secondly, the specificity of these changes for malaria compared with that of acute infection remains unknown. These are exciting avenues yet to be explored.
Iron metabolism is equally interesting in malaria. Both this study [1] and another [9] have shown a fall in serum iron and transferrin, but once again how specific they are for malaria and whether they contribute to the anaemia, or are merely a byproduct of the infection, are unanswered questions. A dramatic rise in serum ferritin was documented in the present study in uncomplicated cases. Whilst this may represent part of the acute phase response it might equally reflect haemolysis, hepatocyte damage or reticuloendothelial system blockade. Whatever the mechanism, the raised ferritin levels in the face of a reduced proportion of ironcontaining erythroblasts in the marrow points to a mechanism which might be rate limiting for erythropoiesis. This 'sequestration' of iron could present a two-edged sword, for if it is implicated in an inadequate marrow response, it might possibly be equally harmful to developing parasites which are said, not without controversy [10] , to require extracellular iron [11] .
Despite the controversial aspects of the subject of anaemia in malaria, in one all are agreed; namely that the mechanisms are both multifactorial and complex. Only a selected few have been discussed here.
